PetMed Express Future Growth

Future criteria checks 3/6

PetMed Express is forecast to grow earnings and revenue by 117.7% and 2.5% per annum respectively. EPS is expected to grow by 117.7% per annum. Return on equity is forecast to be 0.5% in 3 years.

Key information

117.7%

Earnings growth rate

117.74%

EPS growth rate

Specialty Retail earnings growth	10.8%
Revenue growth rate	2.5%
Future return on equity	0.47%
Analyst coverage	Low
Last updated	23 Oct 2025

Recent future growth updates

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 09

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

Recent updates

Getting In Cheap On PetMed Express, Inc. (NASDAQ:PETS) Is Unlikely

Nov 13

Some Confidence Is Lacking In PetMed Express, Inc. (NASDAQ:PETS) As Shares Slide 26%

Apr 09

Cost Cuts And Digital Upgrades Will Strain Future Margins

Apr 06 Optimism regarding savings from PetCareRx integration could jeopardize future profitability if anticipated savings do not materialize.

PetMed Express: Dip Or Rip, A Buy After Earnings

Feb 10

We Think PetMed Express (NASDAQ:PETS) Can Easily Afford To Drive Business Growth

Feb 08

Some PetMed Express, Inc. (NASDAQ:PETS) Shareholders Look For Exit As Shares Take 28% Pounding

Jan 09

PetMed Express: Why (And Why Not) The Rebound Could Continue

Nov 12

Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking

Oct 04

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

Aug 09

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

Earnings and Revenue Growth Forecasts

NasdaqGS:PETS - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2028	211	1	N/A	N/A	1
3/31/2027	205	0	N/A	N/A	1
3/31/2026	199	-5	N/A	N/A	1
9/30/2025	198	-55	-16	-9	N/A
6/30/2025	212	-44	-5	1	N/A
3/31/2025	227	-6	0	5	N/A
12/31/2024	237	0	1	5	N/A
9/30/2024	249	-1	-1	3	N/A
6/30/2024	262	-3	-9	-5	N/A
3/31/2024	274	-7	0	4	N/A
12/31/2023	277	-3	2	7	N/A
9/30/2023	270	-1	17	22	N/A
6/30/2023	265	1	17	22	N/A
3/31/2023	248	5	23	28	N/A
12/31/2022	259	9	23	27	N/A
9/30/2022	261	13	19	23	N/A
6/30/2022	263	17	23	25	N/A
3/31/2022	272	19	17	18	N/A
12/31/2021	279	22	26	28	N/A
9/30/2021	284	25	24	26	N/A
6/30/2021	292	27	48	51	N/A
3/31/2021	304	24	38	40	N/A
12/31/2020	312	31	37	39	N/A
9/30/2020	306	30	34	37	N/A
6/30/2020	300	28	25	28	N/A
3/31/2020	284	26	37	39	N/A
12/31/2019	274	25	33	35	N/A
9/30/2019	275	26	41	42	N/A
6/30/2019	276	31	N/A	23	N/A
3/31/2019	283	38	N/A	45	N/A
12/31/2018	286	41	N/A	34	N/A
9/30/2018	286	43	N/A	39	N/A
6/30/2018	282	41	N/A	46	N/A
3/31/2018	274	37	N/A	37	N/A
12/31/2017	270	35	N/A	51	N/A
9/30/2017	262	30	N/A	38	N/A
6/30/2017	256	27	N/A	48	N/A
3/31/2017	249	24	N/A	47	N/A
12/31/2016	242	22	N/A	30	N/A
9/30/2016	240	22	N/A	35	N/A
6/30/2016	236	21	N/A	23	N/A
3/31/2016	235	21	N/A	21	N/A
12/31/2015	229	20	N/A	25	N/A
9/30/2015	228	20	N/A	22	N/A
6/30/2015	228	18	N/A	29	N/A
3/31/2015	229	17	N/A	32	N/A
12/31/2014	228	17	N/A	25	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PETS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.3%).

Earnings vs Market: PETS is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: PETS is expected to become profitable in the next 3 years.

Revenue vs Market: PETS's revenue (2.5% per year) is forecast to grow slower than the US market (10.7% per year).

High Growth Revenue: PETS's revenue (2.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: PETS's Return on Equity is forecast to be low in 3 years time (0.5%).

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/24 09:10
End of Day Share Price	2025/12/24 00:00
Earnings	2025/09/30
Annual Earnings	2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PetMed Express, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Erin Wilson Wright	BofA Global Research
Kristine Koerber	Citizens JMP Securities, LLC
David Westenberg	CL King & Associates, Inc.

PetMed Express Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Price target decreased by 8.3% to US$2.75

Price target decreased by 10% to US$3.00

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Price target decreased by 21% to US$7.75

Price target decreased by 18% to US$15.00

Recent updates

Cardone Ventures, LLC proposed to acquire PetMed Express, Inc. (NasdaqGS:PETS) for $89.3 million.

SilverCape Investments Limited proposed to acquire remaining 87.90% stake in PetMed Express, Inc. (NasdaqGS:PETS) for $73.9 million.

PetMed Express, Inc., Annual General Meeting, Jan 21, 2026

PetMed Express Receives Non-Compliance Notice from Nasdaq

Getting In Cheap On PetMed Express, Inc. (NASDAQ:PETS) Is Unlikely

Price target decreased by 8.3% to US$2.75

PetMed Express, Inc. Appoints James LaCamp to the Board of Directors and Chair of the Audit Committee of the Board, Effective October 30, 2025

Full year 2025 earnings: EPS and revenues miss analyst expectations

Price target decreased by 10% to US$3.00

Petmed Express, Inc. Receives Notice of Non-Compliance with Nasdaq Listing Rules

PetMed Express, Inc. Announces Chief Executive Officer Changes, Effective August 11, 2025

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

PetMed Express, Inc. announced delayed annual 10-K filing

PetMed Express, Inc. to Report Q4, 2025 Results on Jun 10, 2025

SilverCape Investments Limited Intends to Engage with PetMed Express, Inc

President recently sold US$200k worth of stock

PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors, Effective April 09, 2025

Some Confidence Is Lacking In PetMed Express, Inc. (NASDAQ:PETS) As Shares Slide 26%

Cost Cuts And Digital Upgrades Will Strain Future Margins

Third quarter 2025 earnings: EPS and revenues miss analyst expectations

PetMed Express: Dip Or Rip, A Buy After Earnings

We Think PetMed Express (NASDAQ:PETS) Can Easily Afford To Drive Business Growth

PetMed Express, Inc. to Report Q3, 2025 Results on Feb 10, 2025

Some PetMed Express, Inc. (NASDAQ:PETS) Shareholders Look For Exit As Shares Take 28% Pounding

Independent Chairman of the Board recently bought US$325k worth of stock

PetMed Express: Why (And Why Not) The Rebound Could Continue

New minor risk - Share price stability

Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

PetMed Express, Inc. to Report Q2, 2025 Results on Nov 06, 2024

Optimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking

PetMed Express, Inc. Appoints Robyn DElia as Chief Financial Officer, Effective September 16, 2024

New major risk - Revenue and earnings growth

PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

New minor risk - Share price stability

First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

Petmed Express, Inc. Appoints Doug Krulik as Chief Accounting Officer, Effective August 19, 2024

PetMed Express, Inc. to Report Q1, 2025 Results on Aug 06, 2024

PetMed Express, Inc.(NasdaqGS:PETS) dropped from Russell 3000 Index

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.13 profit in 2Q 2023)

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded